Here's What Key Metrics Tell Us About Ionis Pharmaceuticals (IONS) Q2 Earnings

Ionis Pharmaceuticals (IONS) reported $452 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 100.9%. EPS of $0.86 for the same period compares to -$0.45 a year ago. Here is how Ionis Pharmaceuticals performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for Ionis Pharmaceuticals here>>> Shares of Ionis Pharmaceuticals have returned +3.9% over the past month versus the ...